Overview

Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve Subjects

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare PEG-interferon alfa-2b and two different doses of rivavirin for the treatment of chronic hepatitis C in previously untreated adult subjects

Phase:

Phase 3

Details

Lead Sponsor:

Weill Medical College of Cornell University

Collaborator:

Schering-Plough

Treatments:

Peginterferon alfa-2b
Ribavirin